Article
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
The Journal of biological chemistry - 10 Aug 2018
Sudom Athena, Talreja Santosh, Danao Jean, Bragg Eric, Kegel Rob, Min Xiaoshan, Richardson Jason, Zhang Zhongqi, Sharkov Nikolai, Marcora Edoardo, Thibault Steve, Bradley Jodi, Wood Steve, Lim Ai-Ching, Chen Hang, Wang Songli, Foltz Ian N, Sambashivan Shilpa, Wang Zhulun
Abstract excerpt
Triggering receptor expressed on myeloid cells 2 (TREM2) is an immune receptor expressed on the surface of microglia, macrophages, dendritic cells, and osteoclasts. The R47H TREM2 variant is a significant risk factor for late-onset Alzheimer's disease (AD), and the molecular basis of R47H TREM2 loss of function is an emerging area of TREM2 biology. Here, we report three high-resolution structures of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
